Sulke, N;
              
      
            
                Dulai, R;
              
      
            
                Freemantle, N;
              
      
            
                Sugihara, C;
              
      
            
                Podd, S;
              
      
            
                Eysenck, W;
              
      
            
                Lewis, M;
              
      
            
            
          
      
            
            
          
      
            
            
            ... Furniss, SS; + view all
            
          
      
        
        
        
    
  
(2021)
  Long Term outcomes of percutaneous atrial fibrillation ablation in patients with continuous monitoring.
PACE: Pacing and Clinical Electrophysiology
, 44
       (7)
    
     pp. 1176-1184.
    
         10.1111/pace.14282.
  
  
      
    
  
Preview  | 
            
              
Text
 Freemantle_Final manuscript.pdf - Accepted Version Download (235kB) | Preview  | 
          
Abstract
INTRODUCTION: There is limited data using continuous monitoring to assess outcomes of atrial fibrillation (AF) ablation. This study assessed long-term outcomes of AF ablation in patients with implantable cardiac devices. METHODS: 207 patients (mean age 68.1 ± 9.5, 50.3% men) undergoing ablation for symptomatic AF were followed up for a mean period of 924.5 ± 636.7 days. Techniques included The Pulmonary Vein Ablation Catheter (PVAC) (59.4%), cryoablation (17.4%), point by point (14.0%) and The Novel Irrigated Multipolar Radiofrequency Ablation Catheter (nMARQ) (9.2%). RESULTS: 130 (62.8%) patients had paroxysmal AF (PAF) and 77 (37.2%) persistent AF. First ablation and repeat ablation reduced AF burden significantly (relative risk 0.91, [95% CI 0.89 to 0.94]; P <0.0001 and 0.90, [95% CI, 0.86-0.94]; P <0.0001). Median AF burden in PAF patients reduced from 1.05% (interquartile range [IQR], 0.1%-8.70%) to 0.10% ([IQR], 0%-2.28%) at one year and this was maintained out to four-years. Persistent AF burden reduced from 99.9% ([IQR], 51.53%-100%) to 0.30% ([IQR], 0%-77.25%) at one year increasing to 87.3% ([IQR], 4.25%-100%) after four years. If a second ablation was required, point-by-point ablation achieved greater reduction in AF burden (relative risk, 0.77 [95% CI, 0.65-0.91]; P <0.01). CONCLUSION: Ablation reduces AF burden both acutely and in the long-term. If a second ablation was required the point-by-point technique achieved greater reductions in AF burden than "single-shot" technologies. Persistent AF burden increased to near pre ablation levels by year 4 suggesting a different mechanism from PAF patients where this increase did not occur.
| Type: | Article | 
|---|---|
| Title: | Long Term outcomes of percutaneous atrial fibrillation ablation in patients with continuous monitoring | 
| Open access status: | An open access version is available from UCL Discovery | 
| DOI: | 10.1111/pace.14282 | 
| Publisher version: | https://doi.org/10.1111/pace.14282 | 
| Language: | English | 
| Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. | 
| Keywords: | Atrial fibrillation, ablation, cardiac implantable device, continuous monitoring | 
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Inst of Clinical Trials and Methodology UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Inst of Clinical Trials and Methodology > Comprehensive CTU at UCL  | 
        
| URI: | https://discovery.ucl.ac.uk/id/eprint/10132064 | 
Archive Staff Only
![]()  | 
        View Item | 
                      
